BrainXell Therapeutics Global is advancing iPSC expertise to enable therapeutics to meet the critical needs of those afflicted with neurodegenerative disease. The lead program BXT-110 is in development for clinical readiness within the year addressing Parkinson’s Disease.
This company has no org chart yet
This company has no teams yet
This company has no offices yet